Navigation Links
ShangPharma Appoints Pharmaceutical Executive Dr. Mitchell Reff Chief Biologics Officer
Date:1/13/2014

SHANGHAI, Jan. 13, 2014 /PRNewswire/ -- ShangPharma Corporation is pleased to announce that Dr. Mitchell Reff has joined the company as Chief Biologics Officer. Dr. Reff brings over 30 years of research and development experience in the biopharmaceutical industry. Dr. Reff's appointment further strengthens the world-class technical capabilities of ChemPartner's Biologics Division and offers Pharmaceutical and Biotechnology companies from around the world first-rate strategic and technical expertise to discover and manufacture novel first-in-class and best-in-class biologic clinical development candidates to advance into the Pharmaceutical and Biotechnology company pipelines.

Dr. Reff received his Ph.D. in Medical Microbiology from Stanford University School of Medicine, and his Bachelor's degree in Chemistry from Massachusetts Institute of Technology. This was followed by a  Postdoctoral Fellowship at Harvard Medical School, and  a position at the National Cancer Institute. Dr. Reff then spent 8 years at SmithKline Laboratories working on gene expression in mammalian cells and protein engineering. After that, he joined Idec Pharmaceuticals as head of molecular biology in 1990. Dr. Reff had a distinguished 21 year career at Idec, and later at Biogen Idec. He was Vice President Discovery Oncology at Biogen Idec running multiple bicoastal oncology groups developing small molecule and recombinant protein therapeutic molecules for oncology and delivered 6 novel oncology drugs into clinical trials in 5 years.

In early 1990s, Dr. Reff was Project Leader targeting B cell lymphoma, building and expressing the chimeric mouse-human anti-CD20 monoclonal antibody (Rituxan), the first monoclonal antibody approved to treat a tumor. Dr. Reff led the efforts from discovery until Rituxan entered its pivotal clinical trial.

Dr. Reff is well-recognized in the pharmaceutical and resea
'/>"/>

SOURCE ShangPharma
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. ShangPharma Corporation Announces Completion of Merger
2. ShangPharma Corporation Announces Extraordinary General Meeting of Shareholders
3. ShangPharma Announces Third Quarter 2012 Results
4. ShangPharma to Report Third Quarter 2012 Financial Results on November 20, 2012
5. ShangPharma and Harbour Antibodies Announce Licensing Agreement
6. ShangPharma Announces Second Quarter 2012 Results
7. ShangPharma to Report Second Quarter 2012 Financial Results on August 20, 2012
8. ShangPharma Independent Committee Appoints Financial Advisor
9. ShangPharma Independent Committee Appoints Chairman and Legal Counsel
10. ShangPharma Announces Receipt of "Going Private" Proposal at $8.50 to $9.50 Per ADS
11. ShangPharma Announces First Quarter 2012 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... The Judicial Panel on Multidistrict Litigation (JPML) ... centralize Inferior vena cava (IVC) Filter lawsuits filed against ... have already been centralized by the JPML. ... risk for a pulmonary embolism. The filters are designed ... Claims against Bard and Cook involve incidents of retrievable ...
(Date:7/29/2015)... -- Research and Markets( http://www.researchandmarkets.com/research/h85dj3/pharmaceutical ) ... Market by Packaging Type, by Raw Material, by Drug ... Forecasts to 2020" report to their offering. ... is estimated to reach above $80 Billion by 2020 ... show a steady growth rate in the coming years. ...
(Date:7/29/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/hmjqff/global_wound_care ) has ... Care Markets (Twelve Country Analysis: Germany, France, Italy, ... Brazil, Australia, South Korea)" report to their ... competitive market summary. The wound care market is ... product maturity. Several of the products within the ...
Breaking Medicine Technology:IVC filter litigation continues; law firm provides free information to IVC filter patients 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 2Pharmaceutical Packaging Market by Packaging Type, Raw Material & Drug Delivery Type - Forecasts to 2020 for the $80 Billion Industry 3Global Wound Care Markets 2015 2
... Blood fluoride levels were significantly higher in patients with ... in Biological Trace Element Research (April 2009). ... children and young adults.Randhu and colleagues measured serum fluoride ... patients. Group one had osteosarcoma, group two had non-osteosarcoma ...
... 29 Stallergenes S.A.,announces the release of the first ... on a sublingual house dust mite desensitization tablet. , ... the outcome of this study, which is the first,large ... mites allergen in,treating perennial allergic rhinitis. Furthermore, the unexpected ...
Cached Medicine Technology:Another Study Links Fluoride to Bone Cancer 2Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 2Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 3Stallergenes S.A.: Positive Results From a Phase IIb/III Clinical Trial on the House Dust Mite Desensitization Tablet 4
(Date:7/29/2015)... ... ... Join Luz Delia Gerber and Abbi Ferrin as they share their empowering message ... body actually works. A state of mindfulness allows one to be present and more ... forge this new relationship with their bodies. , Abi Ferrin has a passion for ...
(Date:7/29/2015)... ... ... Ticket Down is a reliable source of authentic tickets for the international friendly ... international soccer schedule of matches played on American soil continues to grow each year. ... world’s greatest teams, Brazil, will travel to North America to compete with the United ...
(Date:7/29/2015)... ... July 29, 2015 , ... The NCCA re-accredited the ... expiring November 30, 2019, during its recent meeting. , The Commission received renewal ... program’s compliance with the NCCA’s Standards for the Accreditation of Certification Programs. ...
(Date:7/29/2015)... ... July 29, 2015 , ... On July 26th the ... FDA for nicotine laced liquid products. Their report says cigarette use has decreased ... are particularly troublesome to addiction professionals as many of the candy flavors available ...
(Date:7/29/2015)... (PRWEB) , ... July 29, 2015 , ... ... Campbell Agency has once again teamed up with Stillwaters Cancer Support Services and ... their families. Stillwaters provides individual and family counseling, support groups, workshops and educational ...
Breaking Medicine News(10 mins):Health News:Pampering and Empowerment Abound at Final Event in Luz Delia Gerber’s Book Unveiling 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 2Health News:Cheap USA vs. Brazil Tickets at Gillette Stadium: Ticket Down Cuts Presale Ticket Prices for Brazil vs. USA Men's National Soccer Team (USMNT) at Gillette Stadium 3Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 2Health News:Commission for Case Manager Certification Receives Re-Accreditation of its CCM® credential from the National Commission for Certifying Agencies (NCCA) 3Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 2Health News:Harbor Village Urges South Florida Residents to Abstain from the Use of E Cigarettes 3Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 2Health News:Scott Campbell Agency and Nonprofit Stillwaters Cancer Support Services Initiate New Charity Campaign in Waukesha, WI to Provide Help for People Touched by Cancer 3
... under the responsibility of Marc Peschanski, director of ... stem cells and their therapeutic applications, aimed ... this field, with input from 17 renowned specialists ... stem cells, mesenchymatic, hematopoetic, and organ stem cells ...
... completed its acquisition of BioVeris. Roche signed the ... on April 4, 2007. ,This ... Electrochemiluminescence (ECL) technology and can expand its immunochemistry ... market segments such as life sciences research, life ...
... bitten and injured by a jackal in Bihar's Gopalganj district, ... to treat the patients. ,In the ... - including women and children - in half a dozen ... km from here. ,The injured are being treated ...
... to introduce organic farming in India with the help ... organic village will be set up in each of ... Ngodup Dorje, head of the agriculture and cooperative division ... villages will receive all inputs in the process of ...
... on drugs has officially declared Britain the cocaine capital of ... over 900,000 Britons buy cocaine, which means the country has ... addition, Britain's 350,000 heroin users are the largest number in ... from the UN's Office on Drugs and Crime also said ...
... among prisoners than among the general population of Thailandone study, ... that 25% of prisoners who agreed to be tested were ... the national population. ,But Thailands prisons, say Ford ... severe budgetary constraints that impede the effective delivery of HIV ...
Cached Medicine News:
HME only...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to ...
Indications For Usage: ,Adult (recommended tidal volume >150ml), single patient use on anesthetized patients and respiratory care patients who require a breathing circuit. The product is intended to...
... T helps provide protection to the exposed airway ... extremely lightweight making it ideal for active young ... rate of heat and moisture recovery, it ensures ... HMEs and filters have ISO standard tapered ends ...
Medicine Products: